Novartis CEO Vas Narasimhan on Drug Development & AI's Role in Disease Treatment
Inside the ICE House
•
30m
The pharmaceutical industry is experiencing extraordinary innovation, fueled by breakthroughs in science, technology, and data analytics. Novartis (NYSE: NVS) stands as a driving force in this wave of transformation. From gene and cell therapies to targeted cancer treatments and immunology, Novartis consistently delivers solutions for some of the most complex health problems. CEO Vas Narasimhan goes Inside the ICE House to discuss the significant success achieved and how the company, under his leadership, sharpened its focus on innovative medicines to combat some of the world's most pressing medical challenges.
Up Next in Inside the ICE House
-
History Series: The NY Railroads that...
Long before today’s transit systems became everyday routines, New York’s growth was propelled by ambitious railroads that stitched the region together through public investment and engineering daring. Historian Justin Rivers joins Anna Melo and NYSE archivist Dave D’Onofrio Inside the ICE House t...
-
Author Rishad Tobaccowala on Retraini...
The workforce is experiencing a profound transformation, fueled by rapid technological advancements, shifting societal values, and evolving employee expectations. This evolution requires a rethinking of traditional work structures, investing in digital tools, and fostering people-first cultures. ...
-
ADL CEO Jonathan Greenblatt on Fighti...
ADL CEO Jonathan Greenblatt goes Inside the ICE House to explore how the ADL is tackling the rising and rapidly shifting threat of antisemitism. He reflects on how hatred has evolved from fringe extremism to viral online campaigns that challenge traditional defenses. Jonathan also breaks down the...
